Updated Jan 27, 2022 ยท v4.13.200-prod
RxKinect Study Patient App
You are invited to participate in the Neurocrine Biosciences RX-KINECT Participant study to evaluate INGREZZA for the treatment of TD. This app is specifically intended for study participants in the Neurocrine Biosciences RX-KINECT Participant study only. The application uses HealthKit and Apple's ResearchKit library to conduct clinical trials.
4 years on Google Play
This app isn't currently appearing in any tracked top charts.